Long-term follow-up of tongue dysphagia treatment
Part of Digestive system, Ear, nose & throat clinical trials.
This study is for people who already received the experimental treatment iltamiocel for tongue dysphagia in the REVIVE trial. It monitors your health and swallowing over a longer period to understand how well the treatment works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have already completed the 24-month visit in the REVIVE study.
- You must have received iltamiocel (not a placebo) during the REVIVE study.
- You must be willing to follow study procedures and sign a consent form.
- You must be available for follow-up visits as the study requires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to measure how well your throat and voice box work during swallowing. It may help doctors better understand swallowing problems and improve care.
This study checks what happens years later to people who already finished an earlier trial for a surgical sealant. It helps doctors know how well the treatment works over time.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This study is for people who have already received Q-Cells treatment. It does not test new treatments; instead, it checks on your health over a long time to see how you are doing.
This study helps people recovering from head and neck cancer improve their quality of life after treatment. It focuses on swallowing therapy and rehabilitation to help you feel better and function more normally after chemotherapy, radiation, or surgery.
This Phase 1 study is a follow-up “rollover” for people who already completed the 12-month visit of an earlier study. It checks what happens next after that prior study and may help doctors understand the ongoing safety and effects of the treatment.
Hear when a new Oropharyngeal Dysphagia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.